Stocktoria
Bluejay Diagnostics, Inc. BJDX
Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2021-11-10
Bluejay Diagnostics, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Gross margin | — | — | — | 19.6% | — | — |
| Operating margin | — | — | — | -3741.5% | — | — |
| Net margin | — | — | — | -3733.1% | — | — |
| FCF margin | — | — | — | -3590.1% | — | — |
| Return on assets | -96.2% | -115.9% | -204.5% | -68.8% | -16.6% | -76.3% |
| Return on equity | -114.6% | -134.7% | -343.8% | -80.6% | -17.1% | 27.5% |
| Current ratio | 4.88 | 6.05 | 1.82 | 7.19 | 32.43 | — |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.